The economics of prevention: How maternal RSV immunisation can strengthen public health systems
This global trend is reflected in the Middle East and North Africa region, where RSV is the leading cause of acute respiratory tract infections in young children. In addition to causing LRTIs, RSV leads to over three million hospital admissions and nearly 60,000 deaths globally in children under five each year.
Maternal vaccinations not only help protect one of the most vulnerable population groups but also support national healthcare systems and economies by reducing both direct and indirect costs.
The economic impact of infant RSV
The health impact of RSV in infants results in a heavy burden on national healthcare systems. In Dubai alone, a recent 10-year retrospective cohort study showed that nearly half of patients with RSV were aged under 2 years; of these patients, 22 per cent were hospitalised with an average hospital stay of four days and a hospitalisation cost of US$9.8 million.
Meanwhile, in Saudi Arabia, researchers recently projected that if nothing changes, RSV will drive roughly 86,000 infant hospitalisations and US$817.9 million in associated medical costs over the next five years. However, the economic impact of RSV in infants extends beyond the hospital, as parents often miss work to care for their sick infants, leading to a loss in economic productivity.
The science behind maternal vaccines
Maternal vaccines leverage the natural infant protection mechanism that occurs during pregnancy, providing a boost to the levels of antibodies to shield infants during the first months of life before they are eligible to receive vaccines directly. This transfer of antibodies from mother to fetus is so efficient that by the time a baby is born at full term, the concentration of antibodies in the baby's blood is often even higher than in the mother's.
Maternal vaccines have come a long way since the 1800s, when it was first observed that infants born to women vaccinated against smallpox during pregnancy were protected in early life. Today, pharmaceutical leaders are constantly investing in research and development (R&D) efforts related to maternal vaccines while prioritising the safety of both mother and child.
Pfizer has leveraged years of vaccines expertise and new scientific discoveries to bring forward a maternal RSV vaccine with the potential to harness a mother's natural ability to provide protection to growing babies through the transfer of antibodies in the womb. This maternal immunisation is currently helping to protect infants in their vulnerable first months of life from disease caused by this highly contagious virus.
The potential impact of maternal RSV vaccines
By preventing RSV in infants, maternal vaccinations have the potential to reduce the economic impact of the disease. According to recent research, increasing the uptake of the maternal vaccine in KSA to 90 per cent will have a budget impact of US$741.8 million, compared to US$1,689.7 million with a 25 per cent uptake.
In addition to direct medical costs, costs related to parent absenteeism will also be reduced, resulting in a more productive and efficient economy. Reducing the impact of RSV in infants will also free up hospital beds, making way for other urgent infant healthcare needs, resulting in a stronger healthcare infrastructure. Beyond the economic impact of maternal RSV vaccines, and of much higher importance, preventing RSV in infants has the potential to safeguard infant lives and can contribute to national government efforts to reduce infant mortality rates.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
20 minutes ago
- Zawya
Egypt: Opella becomes first global consumer healthcare firm to gain B Corp status
Egypt - Opella has become the first global consumer healthcare company to achieve B Corp Certification after meeting the social and environmental standards set by B Lab, the non-profit organisation behind the accreditation. The certification covers Opella's global operations and follows a four-year transformation process, during which the company said it redefined its approach to sustainability, innovation and governance. The company demonstrated strong performance in areas including climate action, product sustainability, community health and leadership accountability. 'Being B Corp certified globally is a first step on our sustainability journey,' Julie Van Ongevalle, Opella President and CEO, said in a statement. 'We owe it to the incredible work done by our 11,000 employees across the globe, our customers and our consumers. It is a commitment to redefine self-care by proving that business success and sustainability can and must go hand in hand.' The company cited several achievements on its path to certification, including a 64% reduction in its Scope 1 and 2 greenhouse gas emissions since 2019 and sourcing over 93% of its electricity from renewable sources. As of 2024, 97% of Opella's paper-based packaging comes from certified or recycled materials. Opella also reported that its partnerships with local non-governmental organisations on community programmes have directly benefited over one million people since 2022. In 2024 alone, its educational campaigns on health awareness and responsible medicine use reached over 129 million individuals. 'This recognition reflects the ambition that drives us forward,' said Marissa Saretsky, Chief Sustainability Officer. 'Going through the certifying process has been an amazing catalyst to drive our sustainability transformation, spur innovation, and engage our employees. It sets a global benchmark, and we are committed to leading from the front by turning high standards into everyday action. This is just the beginning.' Feirouz Ellouze, General Manager for Opella in Africa, the Middle East and Turkiye, added that the certification marks the beginning of a deeper commitment. 'B Corp certification marks the beginning of our journey to deepen our commitment to environmental stewardship,' Ellouze said. 'At Opella, we believe that our mission to bring health into the hands of our consumers is inseparable from our responsibility to care for the planet. Sustainability isn't a side initiative—it's a core part of who we are and what we do. We can't deliver health without honoring the planet—because true well-being begins with a thriving world.'
Khaleej Times
12 hours ago
- Khaleej Times
Warrior Academy takes new approach to martial arts training in Dubai
Warrior Academy, a specialised training centre for martial arts, recently opened its first branch in Dubai. Rooted in the Warrior Method, a revolutionary approach to child development created its founder and martial arts expert Sebastian Bates, the programme focuses not only on physical skills but also on fostering mental and emotional resilience. Excerpts from an interview: What inspired the launch of Warrior Academy in the UAE? We saw a gap in the UAE for real character education. Not just teaching kids how to fight, but helping them build confidence, focus, and integrity. The UAE gave us the perfect space to scale our impact. It's a region that values leadership and growth, and we're here to develop that in the next generation. How does the Warrior Method differ from traditional martial arts training? Our method comes from my best-selling book The Warrior Method, which details our four-step system: Community, Inspire, Challenge, Lead. It's a structure that builds the three Cs in children—Confidence, Conduct, and Concentration. We use martial arts as a vehicle to give kids a black belt in character. What age groups benefit most from your Confidence Accelerator Programme? We train children from the age of 2 and up, and we've seen remarkable transformation at every stage. But between the ages of 7 and 13 is where growth becomes exponential. That's when identity locks in. We don't exclude younger or older students—we've simply built a programme that supports every age with the right challenge. How do you measure personal growth in children? We're the only martial arts academy in the world using software and AI to deeply track a child's development. We measure changes in Confidence, Conduct, and Concentration—and we show parents a clear before and after. On average, kids in our programme see an 82% boost in confidence in their first year. This data has earned us national media attention in four countries. No fluff. Just real, measurable growth. What role does character development play in your curriculum? It's everything. Skill without character is dangerous. Most academies teach techniques. We teach purpose. We don't just train fighters—we shape leaders. Too many places chase belts and trophies. We focus on lifelong values. It's a completely different philosophy, and it's why our students stand out on and off the mats. Can you share a success story from one of your students? We had one boy come in after experiencing some serious bullying— he was shut down and full of fear. Within a year, he stood on stage and gave a confident speech in front of hundreds of parents. Another student with autism struggled with communication. Martial arts gave him structure, a sense of belonging, and now he's mentoring younger students. That's transformation. How is the academy contributing to global social impact? For every paying member, we sponsor two vulnerable children in slums across the world. Right now, we teach over 6,000 children weekly across seven countries in five continents. By the end of this year, that number will hit 15,000. In the heart of the world's biggest slums, every child we support receives a hot meal—often the only one they'll eat that day—before they train. It's a full-circle programme that changes lives, not just habits. What's next for Warrior Academy in the region? Due to high demand, we're opening three new academies: Jumeirah Islands (Sept 2025), Khalifa City in Abu Dhabi (Jan 2026), and Silicon Oasis (Sept 2026). These dates are tentative, but interest is exploding—we already have paid waiting lists. After our Jumeirah launch, over 1,000 parents have applied to join. The demand is real, and we're building to meet it.
Zawya
13 hours ago
- Zawya
Hexavalent in Senegal: A step forward for immunization coverage and child health
On the morning of July 1, 2025, Aissatou, a young mother from Diamniadio, arrived early at the health center, her two-month-old baby snuggled against her. She hadn't come for a routine consultation—today, her child was receiving the new hexavalent vaccine. 'Before, I was afraid of multiple injections for my baby. Today, the health workers explained to me that a single dose protects against six serious diseases. It's reassuring to know that he'll suffer less while being better protected,' confides Aissatou, gazing at her sleeping son. Like her child, 640,000 infants are targeted this year by the new vaccination schedule. Thanks to the introduction of the hexavalent vaccine, they will be protected against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenzae type B (Hib), and poliomyelitis—all in a single shot. Behind this apparent simplification lies a long process of preparation. The Expanded Programme on Immunization (EPI), with technical and financial support from partners such as Gavi and the World Health Organization (WHO), led an ambitious transition. WHO in particular trained nearly 6,000 health workers, ensured rigorous cold chain management (the vaccine must be kept between +2°C and +8°C), and deployed digital real-time monitoring tools. 'Hexavalent represents a qualitative leap for us vaccinators. A single injection means faster vaccination, less crying, and above all, greater protection,' explains Aminata, a vaccinator in Diamniadio. 1.6 million doses have been positioned across the country's 14 regions. The aim is to achieve at least 90% vaccination coverage by the end of the year. And the expected benefits are considerable: according to Ministry of Health projections, the introduction of this vaccine could halve hospitalizations for the targeted diseases by 2030. For Dr. Badiane, coordinator of the national EPI, this reform marks a turning point: 'It's not just a change of vaccine—it's a new paradigm. We're simplifying the schedule, strengthening immunity, and gaining in effectiveness in the field. WHO's support has been decisive at every stage.' Beyond the numbers and logistics, it's families like Aissatou's who are feeling the change in concrete terms: less stress at each vaccination appointment, a better understanding of health issues, and above all, renewed confidence in the healthcare system. Dr. Jean-Marie Vianny Yameogo, WHO Representative in Senegal, sees this transition as an illustration of health equity: 'Introducing the hexavalent vaccine means offering every Senegalese child the same chance to grow up in good health. It's a concrete commitment to reducing inequalities and building a fairer future for all.' As she leaves the health center, vaccination booklet in hand, Aissatou takes a moment to smile. 'I'll be back for the other doses. My child deserves the best possible protection.' An individual decision—but a collective step towards a healthier future. Distributed by APO Group on behalf of World Health Organization (WHO) - Senegal.
